Asset Details
Do you wish to reserve the book?
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Do you wish to request the book?
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
2021
Overview
Alternative splicing (AS) is a complex coordinated transcriptional regulatory mechanism. It affects nearly 95% of all protein-coding genes and occurs in nearly all human organs. Aberrant alternative splicing can lead to various neurological diseases and cancers and is responsible for aging, infection, inflammation, immune and metabolic disorders, and so on. Though aberrant alternative splicing events and their regulatory mechanisms are widely recognized, the association between autoimmune disease and alternative splicing has not been extensively examined. Autoimmune diseases are characterized by the loss of tolerance of the immune system towards self-antigens and organ-specific or systemic inflammation and subsequent tissue damage. In the present review, we summarized the most recent reports on splicing events that occur in the immunopathogenesis of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) and attempted to clarify the role that splicing events play in regulating autoimmune disease progression. We also identified the changes that occur in splicing factor expression. The foregoing information might improve our understanding of autoimmune diseases and help develop new diagnostic and therapeutic tools for them.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Animals
/ Autoimmune Diseases - etiology
/ Autoimmune Diseases - metabolism
/ Autoimmune Diseases - pathology
/ Autoimmune Diseases - therapy
/ Disease
/ Genes
/ Genetic Predisposition to Disease
/ Genomes
/ Genomics
/ Humans
/ Immunologic diseases. Allergy
/ Ligands
/ Mutation
/ Organ Specificity - genetics
/ Organ Specificity - immunology
/ Proteins
/ Systemic lupus erythematosus
/ therapy
